Klinique Medical Clinic's 2026 revenue guidance is raised, but appears already priced in by the market, CGS International's Kasem Prunratanamala says in a research report. The medical aesthetic clinic operator raised its 2026 revenue target to 4.50 billion baht from THB4.15 billion, citing strong cash sales growth in July, the analyst notes. However, the brokerage leaves its 2026-2028 earnings forecasts unchanged, pending greater clarity on growth sustainability amid intensifying competition and geopolitical headwinds. While the company's operating momentum remains healthy, thanks to drivers including resilient same-store-sale growth, its recent share price strength already captures much of this positive news. The brokerage maintains the stock's hold rating and target price of THB28.00. Shares are 1.75% higher at THB29.00.(ronnie.harui@wsj.com)